Stephen MacMillan

Mr. MacMillan was named President and CEO of Hologic in December 2013 and appointed Chairman in June 2015.

Stephen P. MacMillan was Chairman, President and Chief Executive Officer of Stryker Corporation until February 2012. Mr. MacMillan joined Stryker in 2003 as President and Chief Operating Officer, was appointed CEO effective January 2005, and Chairman in January 2010.

During his 9 years at Stryker, revenues almost tripled from $2.8B to over $8.3B in 2011, and the company moved up over 200 spots on the Fortune 500 list while transforming the company’s quality, compliance and manufacturing operations.

Mr. MacMillan began his career with Procter & Gamble in 1985 and later spent 11 years with Johnson & Johnson in both the U.S. and Europe, and became President of the joint venture between Johnson & Johnson and Merck.

In 2000, he joined Pharmacia Corporation’s Executive Committee, reporting to CEO Fred Hassan, where he oversaw five global businesses with revenues exceeding $2 billion.
Mr. MacMillan has also served on the Board of Directors of Texas Instruments, Alere Inc. and served as a member of President Obama’s Advanced Manufacturing Partnership. Mr. MacMillan currently serves on the Board of Boston Scientific and AdvaMed (the medical device industry’s trade association).

He received a Bachelor of Arts degree in Economics from Davidson College and is a graduate of Harvard Business School’s Advanced Management Program. He is married and has four children.